Yarrow Bioscience Stock (NASDAQ:YARW)
Previous Close
$30.98
52W Range
$14.05 - $46.95
50D Avg
$36.56
200D Avg
$30.71
Market Cap
$520.52K
Avg Vol (3M)
$27.94K
Beta
2.02
Div Yield
$20.10 (66.40%)
YARW Company Profile
Yarrow Bioscience is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The Company's lead product candidate, YB-101, is a potential first-in-class anti-thyroid stimulating hormone receptor (TSHR) monoclonal antibody designed to directly and rapidly disrupt the central mechanism of both Graves' disease (GD) and thyroid eye disease (TED).